Cisplatin-loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Nanoparticles as a Potential Chemotherapeutic Agent against Osteosarcoma

Yi-fei Li Hai-yang Yu Hai Sun Jian-guo Liu Zhao-hui Tang Dan Wang Lian-you Yu Xue-si Chen

Citation:  Yi-fei Li, Hai-yang Yu, Hai Sun, Jian-guo Liu, Zhao-hui Tang, Dan Wang, Lian-you Yu, Xue-si Chen. Cisplatin-loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Nanoparticles as a Potential Chemotherapeutic Agent against Osteosarcoma[J]. Chinese Journal of Polymer Science, 2015, 33(5): 763-771. doi: 10.1007/s10118-015-1624-0 shu

Cisplatin-loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Nanoparticles as a Potential Chemotherapeutic Agent against Osteosarcoma

  • 基金项目:

    This work was financially supported by the National Natural Science Foundation of China (Nos. 51373168, 51233004, 21104076, 51321062 and 51390484), Ministry of Science and Technology of China (International Cooperation and Communication Program 2011DFR51090) and the Program of Scientific Development of Jilin Province (Nos. 20130206066GX, 20130727050YY and 20130521011JH).

摘要: Herein, cisplatin-loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) nanoparticles were evaluated as a potential chemotherapeutic agent against osteosarcoma by using alone or with an iRGD (internalizing RGD, CRGDKDPDC). The release rate of platinum from the cisplatin-loaded nanoparticles CDDP/PLG160-g-mPEG2K (CDDP-NPs) accelerated with the increase of the acidity of the environment. In vitro test demonstrated that CDDP-NPs could inhibit the proliferation of MNNG/Hos osteosarcoma cells with IC50 (72 h) of 12.2 gmL-1. In vivo test for MNNG/Hos osteosarcoma tumor bearing mice exhibited that CDDP-NPs had comparable or slightly higher efficacy but significantly lower side effects in comparison with free CDDP. The coadministration of iRGD could further enhance the anticancer efficacy of CDDP-NPs against MNNG/Hos osteosarcoma without bringing obvious side effects. Therefore, CDDP-NPs using alone or with iRGD have great potential for the treatment of osteosarcoma.

English

    1. [1]

      Kager, L., Zoubek, A., Ptschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., Jundt, G., Kabisch, H., Reichardt, P., Jrgens, H., Gadner, H. and Bielack, S.S., J. Clin. Oncol., 2003, 21(10): 2011

    2. [2]

      Link, M.P., Goorin, A.M., Miser, A.W., Green, A.A., Pratt, C.B., Belasco, J.B., Pritchard, J., Malpas, J.S., Baker, A.R., Kirkpatrick, J.A., Ayala, A.G., Shuster, J.J., Abelson, H.T., Simone, J.V. and Vietti, T.J., N. Engl. J. Med., 1986, 314(25): 1600

    3. [3]

      Bielack, S.S., Kempf-Bielack, B., Delling, G., Exner, G.U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., Zoubek, A., Jrgens, H. and Winkler, K., J. Clin. Oncol., 2002, 20(3): 776

    4. [4]

      Zhang, C., Yao, C., Li, H., Wang, G. and He, X., Int. J. Molecul. Sci., 2014, 15(4): 6544

    5. [5]

      Longhi, A., Fabbri, N., Donati, D., Capanna, R., Briccoli, A., Biagini, R., Bernini, G., Ferrari, S., Versari, M. and Bacci, G., J. Chemother., 2001, 13(3): 324

    6. [6]

      Hughes, D.P., Expert Opinion on Drug Delivery, 2009, 6(12): 1311

    7. [7]

      Longhi, A., Errani, C., De Paolis, M., Mercuri, M. and Bacci, G., Cancer Treat. Rev., 2006, 32(6): 423

    8. [8]

      Wang, D. and Lippard, S.J., Nat. Rev. Drug Discov., 2005, 4(4): 307

    9. [9]

      Stewart, D.J., Dulberg, C.S., Mikhael, N.Z., Redmond, M.D., Montpetit, V.A.J. and Goel, R., Cancer Chemother. Pharmacol., 1997, 40(4): 293

    10. [10]

      Li, Y., Lim, S. and Ooi, C., Pharm. Res., 2012, 29(3): 756

    11. [11]

      van Leeuwen, B.L., Kamps, W.A., Jansen, H.W.B. and Hoekstra, H.J., Cancer Treat. Rev., 2000, 26(5): 363

    12. [12]

      Baba, M., Matsumoto, Y., Kashio, A., Cabral, H., Nishiyama, N., Kataoka, K. and Yamasoba, T., J. Control. Release, 2012, 157(1): 112

    13. [13]

      Plummer, R., Wilson, R., Calvert, H., Boddy, A., Griffin, M., Sludden, J., Tilby, M., Eatock, M., Pearson, D. and Ottley, C., Br. J. Cancer, 2011, 104(4): 593

    14. [14]

      Mi, Y., Zhao, J. and Feng, S.S., Int. J. Pharm., 2012, 438(12): 98

    15. [15]

      Zhang, Y., Wang, X., Guo, M., Yan, H., Wang, C. and Liu, K., Chinese J. Polym. Sci., 2014, 32(10): 1329

    16. [16]

      Mei, L., Fu, L., Shi, K., Zhang, Q., Liu, Y., Tang, J., Gao, H., Zhang, Z. and He, Q., Int. J. Pharm., 2014, 468(12): 26

    17. [17]

      Li, C., Li, Y., Gao, Y., Wei, N., Zhao, X., Wang, C., Li, Y., Xiu, X. and Cui, J., Int. J. Pharm., 2014, 468(12): 15

    18. [18]

      Buckway, B., Wang, Y., Ray, A. and Ghandehari, H., Int. J. Pharm., 2013, 456(1): 202

    19. [19]

      Maeda, H., Wu, J., Sawa, T., Matsumura, Y. and Hori, K., J. Control. Release, 2000, 65(1-2): 271

    20. [20]

      Li, M., Tang, Z., Lv, S., Song, W., Hong, H., Jing, X., Zhang, Y. and Chen, X., Biomaterials, 2014, 35(12): 3851

    21. [21]

      Nishiyama, N., Okazaki, S., Cabral, H., Miyamoto, M., Kato, Y., Sugiyama, Y., Nishio, K., Matsumura, Y. and Kataoka, K., Cancer Res., 2003, 63(24): 8977

    22. [22]

      Song, W., Li, M., Tang, Z., Li, Q., Yang, Y., Liu, H., Duan, T., Hong, H. and Chen, X., Macromol. Biosci., 2012, 12(11): 1514

    23. [23]

      Song, W., Tang, Z., Li, M., Lv, S., Sun, H., Deng, M., Liu, H. and Chen, X., Acta Biomater., 2014, 10(3): 1392

    24. [24]

      Song, W., Tang, Z., Zhang, D., Zhang, Y., Yu, H., Li, M., Lv, S., Sun, H., Deng, M. and Chen, X., Biomaterials, 2014, 35(9): 3005

    25. [25]

      Song, W.T., Li, M.Q., Tang, Z.H., Li, Q.S., Yang, Y., Liu, H.Y., Duan, T.C., Hong, H. and Chen, X.S., Macromol. Biosci., 2012, 12(11): 1514

    26. [26]

      Wilson, R., Plummer, R., Adam, J., Eatock, M., Boddy, A., Griffin, M., Miller, R., Matsumura, Y., Shimizu, T. and Calvert, H., J. Clin. Oncol., 2008, 262573

    27. [27]

      Yu, H., Tang, Z., Song, W., Deng, M. and Chen, X., Chem. J. Chinese U., 2014, 35(5): 903

    28. [28]

      Yu, H., Tang, Z., Li, M., Song, W., Zhang, D., Zhang, Y., Yang, Y., Sun, H., Deng, M. and Chen, X., J. Biomed. Nanotechnol., Accepted

    29. [29]

      Lee, H., Fonge, H., Hoang, B., Reilly, R.M. and Allen, C., Mol. Pharm., 2010, 7(4): 1195

    30. [30]

      Bae, Y.H. and Park, K., J. Control. Release, 2011, 153(3): 198

    31. [31]

      Nichols, J.W. and Bae, Y.H., J. Control. Release, 2014, 190: 451

    32. [32]

      Jain, R.K. and Stylianopoulos, T., Nat. Rev. Clin. Oncol., 2010, 7(11): 653

    33. [33]

      Sugahara, K.N., Teesalu, T., Karmali, P.P., Kotamraju, V.R., Agemy, L., Greenwald, D.R. and Ruoslahti, E., Science, 2010, 328(5981): 1031

    34. [34]

      Hobbs, S.K., Monsky, W.L., Yuan, F., Roberts, W.G., Griffith, L., Torchilin, V.P. and Jain, R.K., Proc. Natl. Acad. Sci. U.S.A., 1998, 95(8): 4607

    35. [35]

      Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D.A., Torchilin, V.P. and Jain, R.K., Cancer Res., 1995, 55(17): 3752

    36. [36]

      Duan, X. and Li, Y., Small, 2013, 9(9-10): 1521

    37. [37]

      Venturoli, D. and Rippe, B., Am. J. Physiol. Renal Physiol., 2005, 288(4): F605

    38. [38]

      Yuan, F., Semin. Radiat. Oncol., 1998, 8(3): 164

    39. [39]

      Wang, Z., Ma, G., Zhang, J., Lin, W., Ji, F., Bernards, M.T. and Chen, S., Langmuir, 2014, 30(13): 3764

    40. [40]

      Huang, Y., Tang, Z., Zhang, X., Yu, H., Sun, H., Pang, X. and Chen, X., Biomacromolecules, 2013, 14(6): 2023

  • 加载中
计量
  • PDF下载量:  0
  • 文章访问数:  1095
  • HTML全文浏览量:  102
文章相关
  • 发布日期:  2015-05-05
  • 收稿日期:  2014-09-17
  • 修回日期:  2014-10-28
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章